abstract |
This invention pertains to the formulation of small-particle suspensions of anticonvulsants, particularly carbamazepine, for pharmaceutical use. This invention also pertains to the formulation of a small-particle suspensions of immunosuppressive agents, particularly cyclosporin, for pharmaceutical use. The particles are coated with one or more surface modifiers. |